文献速递关节外科

病态肥胖是翻修全膝关节置换术后再手术的重要危险因素

Morbid Obesity in Revision Total Knee Arthroplasty: A Significant Risk Factor for Re-Operation.
PubMed 文献 · J Arthroplasty · 2019-01-14

本研究匹配比较了87例病态肥胖(BMI>40 kg/m²)与非病态肥胖(BMI<40 kg/m²)患者初次翻修全膝关节置换术后的手术与临床结局,随访至少5年。病态肥胖组再手术率和再翻修率显著更高,10年生存率更低,临床评分更差。作者认为应告知这类患者再手术可能性更高且结果可能不佳。

要点

  • 病态肥胖组再手术率为34.5%(30/87),非病态肥胖组为16.1%(14/87),P=.005。
  • 病态肥胖组再翻修率为27.6%(24/87),非病态肥胖组为12.6%(11/87),P=.014。
  • 病态肥胖组翻修术后10年再手术和再翻修生存率显著更低(P=.05和P=.014)。

核心结论

  • 病态肥胖患者行翻修全膝关节置换术后再手术和再翻修风险更高,临床结局评分更低。
  • 作者认为应告知这类患者再手术可能性更高且结果可能不佳。

研究设计与样本

  • 匹配对照研究,比较病态肥胖(BMI>40 kg/m²)与非病态肥胖(BMI<40 kg/m²)患者各87例,按翻修时年龄、性别和翻修诊断(无菌性或感染性)1:1匹配,随访至少5年。

主要发现

  • 病态肥胖组再手术率为34.5%(30/87),非病态肥胖组为16.1%(14/87),P=.005。
  • 病态肥胖组再翻修率为27.6%(24/87),非病态肥胖组为12.6%(11/87),P=.014。
  • 病态肥胖组10年再手术生存率(P=.05)和再翻修生存率(P=.014)均显著更低。
  • 无菌性亚组中,病态肥胖组再手术率为29.9%(20/67),非病态肥胖组为13.4%(9/67),P=.021;再翻修率分别为26.9%(18/67)和11.9%(8/67),P=.029。
  • 非病态肥胖组最终WOMAC评分更高(63.1±19.5 vs 55.5±22.5,P=.030),术前至最终KSS变化值更大(45.6±44.3 vs 39.7±48.4,P=.040),SF-12心理成分变化值更大(3.6±10.8 vs -1.4±10.3,P=.013)。

临床怎么用

  • 作者认为应告知病态肥胖患者翻修全膝关节置换术后再手术可能性更高且结果可能不佳。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The purpose of this study is to compare surgical and clinical outcomes between matched groups of morbidly obese (body mass index [BMI] >40 kg/m2) and non-morbidly obese (BMI <40 kg/m2) patients undergoing first-time revision total knee arthroplasty with a minimum 5-year follow-up. METHODS: Two groups of 87 patients (BMI >40 or <40 kg/m2) were matched 1:1 based on age at the time of revision, gender, and diagnosis for revision (aseptic or septic causes). RESULTS: The morbidly obese group had a significantly greater incidence of re-operation (34.5% [30/87] vs 16.1% [14/87], P = .005) and re-revision (27.6% [24/87] vs 12.6% [11/87], P = .014) with a significantly lower 10-year survivorship for re-operation (P = .05) and subsequent revision (P = .014). In particular, the aseptic sub-group had a greater incidence of re-operation (29.9% [20/67] vs 13.4% [9/67], P = .021) and re-revision (26.9% [18/67] vs 11.9% [8/67], P = .029). The non-morbidly obese group demonstrated higher final Western Ontario and McMaster Universities Index scores (63.1 ± 19.5 vs 55.5 ± 22.5, P = .030) and a greater change between pre-operative and final KSS (45.6 ± 44.3 vs 39.7 ± 48.4, P = .040) and SF-12 Mental component (3.6 ± 10.8 vs -1.4 ± 10.3, P = .013). CONCLUSION: Morbidly obese patients undergoing revision total knee arthroplasty have a greater risk of re-operation and re-revision while experiencing lower clinical outcome scores compared to non-morbidly obese patients. These patients should be informed of the higher potential for re-operation and the possibility of poor results.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Sisko ZW, Vasarhelyi EM, Somerville LE, et al. Morbid Obesity in Revision Total Knee Arthroplasty: A Significant Risk Factor for Re-Operation. J Arthroplasty. 2019. PMID: 30745083. doi:10.1016/j.arth.2019.01.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。